According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting weight-loss medications in 2023.

VIVUS, in collaboration with PharmaAccess, its marketing partner in the Middle East North African (MENA) region, intends to provide healthcare providers with more treatment options to combat this ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...

He asked for Adipex, an appetite suppressant ... doctors should always prioritize patient safety and long-term health over quick fixes. Moore-Ruffin says that before taking any medication ...

Campbell, California Tuesday, March 11, 2025, 17:00 Hrs [IST] ...